Alluxa Develops Thin Films for COVID-19 Detection Devices
April 27, 2020
Alluxa is currently supplying OEM qPCR-specific optical filters which are assembled into medical instruments globally for use in PCR testing of individuals.
According to CCO, Peter Egerton, “As an ‘essential business’ in this trying time, we have moved quickly to offer our optical coating expertise and stand ready to help with the deployment, improvement, or development of technologies including qPCR to help slow the pandemic. We are grateful for our dedicated team of engineers and support personnel, our customers, and their collective experience and commitment to help fight this virus by any means necessary.”
The company provides thin-film optics for a wide variety of applications, including autonomous vehicles, telecommunications, robotics, semiconductors, and defense. To learn more about Alluxa’s breakthrough optical coating technologies for COVID-19 detection, please visit: https://www.alluxa.com/optical-filter-catalog/shopby/application-pcr.html. For product details on Alluxa’s full line of high-performance, thin-film optical filters, go to: https://www.alluxa.com/optical-filters/.
Alluxa designs and manufactures next generation, hard coated optical filters using a proprietary plasma deposition process in Santa Rosa, CA. Alluxa’s unique, purpose-built deposition platform and control systems were designed, developed, and built by our team to address the demanding requirements of the next generation of systems and instruments and to create the world’s most challenging filters at breakthrough price points.
Browse our selection of optical filters for sale.
Contact us for a quote on a custom optical filter.